Connection

Michael Rose to Humans

Back to Details
This is a "connection" page, showing publications Michael Rose has written about Humans.
Michael Rose
Connection Strength
0.699
Humans
  1. Validity of Fitbit activity monitoring for adults with progressive muscle diseases. Disabil Rehabil. 2022 Dec; 44(24):7543-7553.
    View in: PubMed
    Score: 0.030
  2. The validity of the International Physical Activity Questionnaire (IPAQ) for adults with progressive muscle diseases. Disabil Rehabil. 2022 Nov; 44(23):7312-7320.
    View in: PubMed
    Score: 0.030
  3. Being Your Best: protocol for a feasibility study of a codesigned approach to reduce symptoms of frailty in people aged 65 years or more after transition from hospital. BMJ Open. 2021 03 05; 11(3):e043223.
    View in: PubMed
    Score: 0.029
  4. Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown. Lancet Respir Med. 2020 07; 8(7):661-663.
    View in: PubMed
    Score: 0.027
  5. Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome. Clin Breast Cancer. 2019 12; 19(6):423-432.e5.
    View in: PubMed
    Score: 0.026
  6. Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases. BMJ Open. 2018 10 03; 8(10):e022083.
    View in: PubMed
    Score: 0.024
  7. Use of a Surgical Debriefing Checklist to Achieve Higher Value Health Care. Am J Med Qual. 2018 Sep/Oct; 33(5):514-522.
    View in: PubMed
    Score: 0.024
  8. SIGECAPS, SSRIs, and Silence - Life as a Depressed Med Student. N Engl J Med. 2018 Mar 22; 378(12):1081-1083.
    View in: PubMed
    Score: 0.024
  9. What explains high life satisfaction in men living with Duchenne muscular dystrophy? A preliminary study to inform psychological intervention. Muscle Nerve. 2017 07; 56(1):163-166.
    View in: PubMed
    Score: 0.022
  10. Four steps toward the control of aging: following the example of infectious disease. Biogerontology. 2016 Feb; 17(1):21-31.
    View in: PubMed
    Score: 0.019
  11. The potential of psychological interventions to improve quality of life and mood in muscle disorders. Muscle Nerve. 2015 Jul; 52(1):131-6.
    View in: PubMed
    Score: 0.019
  12. The great evolutionary divide: two genomic systems biologies of aging. Interdiscip Top Gerontol. 2015; 40:63-73.
    View in: PubMed
    Score: 0.019
  13. It's morning in American health care. JAMA Surg. 2014 Oct; 149(10):1001-2.
    View in: PubMed
    Score: 0.018
  14. Activity rating scales in adult muscle disease: what do they actually measure? Muscle Nerve. 2014 Jul; 50(1):14-23.
    View in: PubMed
    Score: 0.018
  15. Activity rating scales in adult muscle disease: how well do they actually measure? Muscle Nerve. 2014 Jul; 50(1):24-33.
    View in: PubMed
    Score: 0.018
  16. An evolutionary and genomic approach to challenges and opportunities for eliminating aging. Curr Aging Sci. 2014; 7(1):54-9.
    View in: PubMed
    Score: 0.018
  17. A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease. Clin Rehabil. 2014 May; 28(5):508-19.
    View in: PubMed
    Score: 0.017
  18. Role of disease severity, illness perceptions, and mood on quality of life in muscle disease. Muscle Nerve. 2012 Sep; 46(3):351-9.
    View in: PubMed
    Score: 0.016
  19. New experiments for an undivided genetics. Genetics. 2011 May; 188(1):1-10.
    View in: PubMed
    Score: 0.015
  20. Scapular fixation in muscular dystrophy. Cochrane Database Syst Rev. 2010 Jan 20; (1):CD003278.
    View in: PubMed
    Score: 0.013
  21. Adaptation, aging, and genomic information. Aging (Albany NY). 2009 May 21; 1(5):444-50.
    View in: PubMed
    Score: 0.013
  22. Does aging stop? Curr Aging Sci. 2009 Mar; 2(1):3-11.
    View in: PubMed
    Score: 0.013
  23. Evolution of ageing since Darwin. J Genet. 2008 Dec; 87(4):363-71.
    View in: PubMed
    Score: 0.012
  24. Making SENSE: strategies for engineering negligible senescence evolutionarily. Rejuvenation Res. 2008 Apr; 11(2):527-34.
    View in: PubMed
    Score: 0.012
  25. New Applications in Aging Research--a GTCbio conference. IDrugs. 2008 Mar; 11(3):179-80.
    View in: PubMed
    Score: 0.012
  26. Quality of life: listen to, change, or shoot the messenger? Neurology. 2007 Apr 03; 68(14):1095-6.
    View in: PubMed
    Score: 0.011
  27. Do longevity mutants always show trade-offs? Exp Gerontol. 2006 Oct; 41(10):1055-8.
    View in: PubMed
    Score: 0.010
  28. Caloric restriction increases longevity substantially only when the reaction norm is steep. Biogerontology. 2006 Jun; 7(3):161-4.
    View in: PubMed
    Score: 0.010
  29. Neurological disorders in Gulf War veterans. Philos Trans R Soc Lond B Biol Sci. 2006 Apr 29; 361(1468):605-18.
    View in: PubMed
    Score: 0.010
  30. A revolution for aging research. Biogerontology. 2006 Aug; 7(4):269-77.
    View in: PubMed
    Score: 0.010
  31. Charcot-Marie-Tooth disease impairs quality of life: why? And how do we improve it? Neurology. 2005 Sep 27; 65(6):790-1.
    View in: PubMed
    Score: 0.010
  32. The evolution of late life. Ageing Res Rev. 2006 Feb; 5(1):14-32.
    View in: PubMed
    Score: 0.010
  33. Why dietary restriction substantially increases longevity in animal models but won't in humans. Ageing Res Rev. 2005 Aug; 4(3):339-50.
    View in: PubMed
    Score: 0.010
  34. Rules of evidence for models on trial. Exp Gerontol. 2004 Mar; 39(3):451-2; author reply 453.
    View in: PubMed
    Score: 0.009
  35. Gulf War service is an uncertain trigger for ALS. Neurology. 2003 Sep 23; 61(6):730-1.
    View in: PubMed
    Score: 0.009
  36. Pharmacology, genomics, and the evolutionary biology of ageing. Free Radic Res. 2002 Dec; 36(12):1293-7.
    View in: PubMed
    Score: 0.008
  37. Comparison of the Moorehead-Ardelt quality of life questionnaire and the BODY-Q in Danish patients undergoing weight loss and body contouring surgery. Clin Obes. 2020 Apr; 10(2):e12351.
    View in: PubMed
    Score: 0.007
  38. The BODY-Q Stretch Marks Scale: A Development and Validation Study. Aesthet Surg J. 2018 Aug 16; 38(9):990-997.
    View in: PubMed
    Score: 0.006
  39. Implementation of surgical debriefing programs in large health systems: an exploratory qualitative analysis. BMC Health Serv Res. 2018 03 27; 18(1):210.
    View in: PubMed
    Score: 0.006
  40. Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget. 2016 Nov 01; 7(44):71429-71439.
    View in: PubMed
    Score: 0.005
  41. How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline. Trials. 2016 09 13; 17(1):449.
    View in: PubMed
    Score: 0.005
  42. A protocol to develop clinical guidelines for inclusion-body myositis. Muscle Nerve. 2016 Apr; 53(4):503-7.
    View in: PubMed
    Score: 0.005
  43. Interventions for dysphagia in long-term, progressive muscle disease. Cochrane Database Syst Rev. 2016 Feb 09; 2:CD004303.
    View in: PubMed
    Score: 0.005
  44. Technical Modifications to Prevent Massive Hemothorax Following Sternal Plating. J Card Surg. 2015 Sep; 30(9):691-3.
    View in: PubMed
    Score: 0.005
  45. The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population. Muscle Nerve. 2015 Apr; 51(4):496-500.
    View in: PubMed
    Score: 0.005
  46. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'. Trials. 2014 Jun 25; 15:247.
    View in: PubMed
    Score: 0.005
  47. Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve. 2014 Mar; 49(3):422-30.
    View in: PubMed
    Score: 0.004
  48. Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol. 2013 Sep-Oct; 31(5):767-9.
    View in: PubMed
    Score: 0.004
  49. Separating emotions from consequences in muscle disease: comparing beneficial and unhelpful illness schemata to inform intervention development. J Psychosom Res. 2013 Apr; 74(4):320-6.
    View in: PubMed
    Score: 0.004
  50. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology. 2012 Sep 11; 79(11):1145-54.
    View in: PubMed
    Score: 0.004
  51. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012 Jul; 46(1):9-25.
    View in: PubMed
    Score: 0.004
  52. Attention modulates spinal cord responses to pain. Curr Biol. 2012 Jun 05; 22(11):1019-22.
    View in: PubMed
    Score: 0.004
  53. Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy. J Reconstr Microsurg. 2012 May; 28(4):241-6.
    View in: PubMed
    Score: 0.004
  54. A positive Tinel sign as predictor of pain relief or sensory recovery after decompression of chronic tibial nerve compression in patients with diabetic neuropathy. J Reconstr Microsurg. 2012 May; 28(4):235-40.
    View in: PubMed
    Score: 0.004
  55. Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK. Health Qual Life Outcomes. 2011 Dec 16; 9:114.
    View in: PubMed
    Score: 0.004
  56. A systematic review of quality of life in adults with muscle disease. J Neurol. 2011 Sep; 258(9):1581-92.
    View in: PubMed
    Score: 0.004
  57. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.
    View in: PubMed
    Score: 0.003
  58. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2010 Mar; 20(3):166-73.
    View in: PubMed
    Score: 0.003
  59. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007 Aug; 130(Pt 8):2024-36.
    View in: PubMed
    Score: 0.003
  60. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004 May; 14(5):337-45.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.